Borderline tumours of the ovary: A 37-year experience at a tertiary referral centre.

Autor: McBain R; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia., Kashyap A; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia., Bishop M; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia., Vicario E; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia., Volchek M; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia., Naaman Y; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia., Rajadevan N; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia., Jones A; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia., Neesham D; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia., McNally O; Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.

Publikováno v: The Australian & New Zealand journal of obstetrics & gynaecology [Aust N Z J Obstet Gynaecol] 2024 Oct 21. Date of Electronic Publication: 2024 Oct 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognostic gene expression signature for high-grade serous ovarian cancer

Autor: Millstein, J, Budden, T, Goode, EL, Anglesio, MS, Talhouk, A, Intermaggio, MP, Leong, HS, Chen, S, Elatre, W, Gilks, B, Nazeran, T, Volchek, M, Bentley, RC, Wang, C, Chiu, DS, Kommoss, S, Leung, SCY, Senz, J, Lum, A, Chow, V, Sudderuddin, H, Mackenzie, R, George, J, AOCS Group, Fereday, S, Hendley, J, Traficante, N, Steed, H, Koziak, JM, Köbel, M, McNeish, IA, Goranova, T, Ennis, D, Macintyre, G, Silva De Silva, D, Ramón Y Cajal, T, García-Donas, J, Hernando Polo, S, Rodriguez, GC, Cushing-Haugen, KL, Harris, HR, Greene, CS, Zelaya, RA, Behrens, S, Fortner, RT, Sinn, P, Herpel, E, Lester, J, Lubiński, J, Oszurek, O, Tołoczko, A, Cybulski, C, Menkiszak, J, Pearce, CL, Pike, MC, Tseng, C, Alsop, J, Rhenius, V, Song, H, Jimenez-Linan, M, Piskorz, AM, Gentry-Maharaj, A, Karpinskyj, C, Widschwendter, M, Singh, N, Kennedy, CJ, Sharma, R, Harnett, PR, Gao, B, Johnatty, SE, Sayer, R, Boros, J, Winham, SJ, Keeney, GL, Kaufmann, SH, Larson, MC, Luk, H, Hernandez, BY, Thompson, PJ, Wilkens, LR, Carney, ME, Trabert, B, Lissowska, J, Brinton, L, Sherman, ME, Bodelon, C, Hinsley, S, Lewsley, LA, Glasspool, R, Banerjee, SN, Stronach, EA, Haluska, P, Ray-Coquard, I, Mahner, S, Winterhoff, B, Slamon, D, Levine, DA, Kelemen, LE, Benitez, J, Chang-Claude, J

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology, vol 31, iss 9

BackgroundMedian overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies widely between patients. There are no well-established, gene expression signatures associated with prognosis. The aim of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::af2ade2cd37beaef06d324cec9ddbdab
https://escholarship.org/uc/item/08f3w53b

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Autor: Talhouk A; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.; University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, British Columbia, Canada., George J; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Wang C; Mayo Clinic, Division of Biomedical Statistics and Informatics, Department of Health Science Research, Rochester, Minnesota., Budden T; University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, New South Wales, Australia.; The University of Manchester, CRUK Manchester Institute, Manchester, United Kingdom., Tan TZ; National University of Singapore, Cancer Science Institute of Singapore, Center for Translational Medicine, Singapore, Singapore., Chiu DS; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Kommoss S; Tuebingen University Hospital, Department of Women's Health, Tuebingen, Germany., Leong HS; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Chen S; Cedars-Sinai Medical Center, Center for Cancer Prevention and Translational Genomics, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California., Intermaggio MP; University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, New South Wales, Australia., Gilks B; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Nazeran TM; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Volchek M; Royal Women's Hospital, Anatomical Pathology, Parkville, Victoria, Australia., Elatre W; Department of Pathology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California., Bentley RC; Department of Pathology, Duke University Hospital, Durham, North Carolina., Senz J; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Lum A; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Chow V; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Sudderuddin H; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Mackenzie R; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Leong SCY; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Liu G; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Johnson D; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Chen B; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada., Group A; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, Queensland, Australia.; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia., Alsop J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Banerjee SN; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Gynaecology Unit, London, United Kingdom., Behrens S; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Bodelon C; NCI, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland., Brand AH; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Brinton L; NCI, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland., Carney ME; Department of Obstetrics and Gynecology, University of Hawaii, John A. Burns School of Medicine, Honolulu, Hawaii., Chiew YE; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Cushing-Haugen KL; Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, Washington., Cybulski C; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Ennis D; Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, London, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Fereday S; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Fortner RT; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., García-Donas J; HM Hospitales Centro Integral Oncológico Clara Campal (HM CIOCC), Madrid, Spain., Gentry-Maharaj A; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, United Kingdom., Glasspool R; Department of Medical Oncology, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, United Kingdom., Goranova T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Greene CS; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Haluska P; Mayo Clinic, Department of Oncology, Rochester, Minnesota., Harris HR; Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington., Hendley J; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Hernandez BY; University of Hawaii Cancer Center, Cancer Epidemiology Program, Honolulu, Hawaii., Herpel E; Institute of Pathology and NCT Tissue Bank, University Hospital Heidelberg, Heidelberg, Germany., Jimenez-Linan M; Addenbrooke's Hospital NHS Trust, Department of Pathology, Cambridge, United Kingdom., Karpinskyj C; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, United Kingdom., Kaufmann SH; Mayo Clinic, Department of Oncology, Rochester, Minnesota.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota., Keeney GL; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Kennedy CJ; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Köbel M; Department of Pathology and Laboratory Medicine, Foothills Medical Center, University of Calgary, Calgary, Alberta, Canada., Koziak JM; Alberta Health Services-Cancer Care, Calgary, Alberta, Canada., Larson MC; Mayo Clinic, Division of Biomedical Statistics and Informatics, Department of Health Science Research, Rochester, Minnesota., Lester J; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.; Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California., Lewsley LA; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Lissowska J; M Sklodowska Curie National Research Institute of Oncology, Department of Cancer Epidemiology and Prevention, Warsaw, Poland., Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Luk H; University of Hawaii Cancer Center, Cancer Epidemiology Program, Honolulu, Hawaii., Macintyre G; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Mahner S; Department of Obstetrics and Gynecology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., McNeish IA; Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, London, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Menkiszak J; Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland., Nevins N; Department of Gynaecological Oncology, Westmead Hospital and Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia., Osorio A; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain., Oszurek O; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Palacios J; Hospital Universitario Ramón y Cajal, Pathology Department. IRYCIS. CIBERONC. Universidad de Alcalá, Madrid, Spain., Hinsley S; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Pearce CL; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California., Pike MC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York., Piskorz AM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Ray-Coquard I; Centre Leon Berard and University Claude Bernard Lyon 1, Lyon, France., Rhenius V; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Rodriguez-Antona C; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain.; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain., Sharma R; Pathology West ICPMR Westmead, Westmead Hospital, The University of Sydney, Sydney, New South Wales, Australia.; University of Western Sydney at Westmead Hospital, Sydney, New South Wales, Australia., Sherman ME; Department of Health Sciences Research, Mayo Clinic College of Medicine, Jacksonville, Florida., De Silva D; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Singh N; Department of Pathology, Barts Health National Health Service Trust, London, United Kingdom., Sinn P; Department of Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Slamon D; Division of Hematology and Oncology, Department of Medicine, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California., Song H; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Steed H; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Royal Alexandra Hospital, Edmonton, Alberta, Canada., Stronach EA; Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, London, United Kingdom., Thompson PJ; Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, California., Tołoczko A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Trabert B; NCI, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland., Traficante N; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Tseng CC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Widschwendter M; Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom., Wilkens LR; University of Hawaii Cancer Center, Cancer Epidemiology Program, Honolulu, Hawaii., Winham SJ; Mayo Clinic, Division of Biomedical Statistics and Informatics, Department of Health Science Research, Rochester, Minnesota., Winterhoff B; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota., Beeghly-Fadiel A; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Benitez J; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain., Berchuck A; Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina., Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Brown R; Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Chang-Claude J; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.; University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany., Chenevix-Trench G; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, Queensland, Australia., deFazio A; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Fasching PA; Division of Hematology and Oncology, Department of Medicine, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California.; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., García MJ; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain.; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain., Gayther SA; Cedars-Sinai Medical Center, Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Los Angeles, California., Goodman MT; Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, California., Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Henderson MJ; Children's Cancer Institute, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia., Karlan BY; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.; Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California., Kelemen LE; Hollings Cancer Center and Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina., Menon U; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, United Kingdom., Orsulic S; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.; Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California., Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Wentzensen N; NCI, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland., Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Schildkraut JM; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia., Rossing MA; Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington., Konecny GE; Division of Hematology and Oncology, Department of Medicine, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California., Huntsman DG; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.; University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada., Huang RY; National University of Singapore, Cancer Science Institute of Singapore, Center for Translational Medicine, Singapore, Singapore.; National Taiwan University, School of Medicine, College of Medicine, Taipei City, Taiwan., Goode EL; Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu., Ramus SJ; University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, New South Wales, Australia. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu.; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia., Doherty JA; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu., Bowtell DD; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Anglesio MS; British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada. m.anglesio@ubc.ca David.bowtell@petermac.org jen.doherty@hci.utah.edu s.ramus@unsw.edu.au egoode@mayo.edu.; University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Oct 15; Vol. 26 (20), pp. 5411-5423. Date of Electronic Publication: 2020 Jun 17.

A community-based model of rapid autopsy in end-stage cancer patients.

Autor: Alsop K; Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Thorne H; Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; kConFab, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Sandhu S; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Hamilton A; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia.; Department of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia., Mintoff C; Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia., Christie E; Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia., Spruyt O; Department of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.; Department of Pain and Palliative Care, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Williams S; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., McNally O; Department of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia.; Department of Obstetrics and Gynaecology, the University of Melbourne, Parkville, Victoria, Australia., Mileshkin L; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia., Ananda S; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia., Hallo J; Department of Oncology, the Royal Women's Hospital, Parkville, Victoria, Australia., Loi S; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.; Translational Breast Cancer Genomics and Therapeutics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Scott C; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Savas P; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Translational Breast Cancer Genomics and Therapeutics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Devereux L; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia., O'Brien P; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia., Gunawardena S; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia., Hampson C; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia., Strachan K; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia., Jaravaza RD; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia., Francis V; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia., Young G; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia., Ranson D; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia., Samaranayake R; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia., Stevens D; Tobin Brothers Funerals, Victoria, Australia., Boyle S; Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia., Fedele C; Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.; Department of Pathology, the University of Melbourne, Parkville, Victoria, Australia., Topp M; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Ho G; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Teo ZL; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.; Translational Breast Cancer Genomics and Therapeutics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Taylor RA; Department of Physiology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia., Papargiris MM; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia., Lawrence MG; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia., Wang H; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia., Risbridger GP; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia., Haynes NM; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.; Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Medon M; Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Division of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Johnstone RW; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.; Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Vidacs E; Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Arnau GM; Molecular Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Vergara IA; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Bioinformatics and Cancer Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Papenfuss AT; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.; Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Bioinformatics and Cancer Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., McArthur G; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia., Waring P; Department of Pathology, the University of Melbourne, Parkville, Victoria, Australia., Carvosso S; The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Angel C; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Gyorki D; Division of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; The Department of Surgery, the University of Melbourne, Parkville, Victoria, Australia., Solomon B; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia., Mitchell G; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.; The Jack Brockhoff Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Hereditary Cancer Program, BC Cancer Agency, Vancouver, Canada., Shanley S; The Jack Brockhoff Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Francis PA; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Dawson SJ; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.; Molecular Biomarkers and Translational Genomics Laboratory, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Haffenden A; Department of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Tidball E; Department of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Volchek M; Department of Pathology, the Royal Women's Hospital, Parkville, Victoria, Australia., Pyman J; Department of Pathology, the Royal Women's Hospital, Parkville, Victoria, Australia., Madadin M; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.; Department of Pathology, University of Dammam, Dammam, Saudi Arabia., Leditschke J; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.; Department of Forensic Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia., Cordner S; The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.; Department of Forensic Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia., Shackleton M; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum Cancer, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia., Bowtell DD; Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia.; The Garvan Institute, Sydney, New South Wales, Australia.

Publikováno v: Nature biotechnology [Nat Biotechnol] 2016 Oct; Vol. 34 (10), pp. 1010-1014. Date of Electronic Publication: 2016 Sep 12.